FDA seems intent on demonstrating that companies large and small, as well as board-certified dermatologists, are susceptible to being slapped with warning letters for unapproved drug claims on products marketed as cosmetics.
The latest such warning letter posted to the agency’s website is addressed to Beverly Hills cosmetic surgeon Ronald Moy, creator of the DNAEGF Renewal protocol and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?